Phase II Study of MGI‐114 Administered Intravenously for 5 Days Every 28 Days to Patients With Metastatic Colorectal Cancer
暂无分享,去创建一个
R. Winn | R. Pazdur | J. Abbruzzese | P. Hoff | M. Neubauer | S. Nasta | Steven C. Cohen | Christopher S. George
暂无分享,去创建一个
R. Winn | R. Pazdur | J. Abbruzzese | P. Hoff | M. Neubauer | S. Nasta | Steven C. Cohen | Christopher S. George